170 related articles for article (PubMed ID: 7956947)
21. Transforming growth factor beta 1, interleukin-8 and interleukin-1, in non-small-cell lung tumors.
Colasante A; Mascetra N; Brunetti M; Lattanzio G; Diodoro M; Caltagirone S; Musiani P; Aiello FB
Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):968-73. PubMed ID: 9310021
[TBL] [Abstract][Full Text] [Related]
22. Transforming growth factor-beta negatively modulates proliferation and c-fos expression of the human endometrial adenocarcinoma cell line HEC-1-A.
Bergman CA; Talavera F; Christman GM; Baker VV; Roberts JA; Menon KM
Gynecol Oncol; 1997 Apr; 65(1):63-8. PubMed ID: 9103392
[TBL] [Abstract][Full Text] [Related]
23. 1,25-Dihydroxyvitamin D3 enhances the expression of transforming growth factor beta 1 and its latent form binding protein in cultured breast carcinoma cells.
Koli K; Keski-Oja J
Cancer Res; 1995 Apr; 55(7):1540-6. PubMed ID: 7882362
[TBL] [Abstract][Full Text] [Related]
24. Mesenchymal-epithelial interactions and transforming growth factor-beta 1 expression during normal and abnormal prostatic growth.
Timme TL; Truong LD; Slawin KM; Kadmon D; Park SH; Thompson TC
Microsc Res Tech; 1995 Mar; 30(4):333-41. PubMed ID: 7541677
[TBL] [Abstract][Full Text] [Related]
25. TGF-beta 1 in colonic neoplasia. A genetic molecular and immunohistochemical study.
Cardillo MR; Yap EP
Arch Anat Cytol Pathol; 1996; 44(5-6):241-9. PubMed ID: 9339011
[TBL] [Abstract][Full Text] [Related]
26. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.
Tuxhorn JA; Ayala GE; Smith MJ; Smith VC; Dang TD; Rowley DR
Clin Cancer Res; 2002 Sep; 8(9):2912-23. PubMed ID: 12231536
[TBL] [Abstract][Full Text] [Related]
27. Mesenchymal-epithelial interactions and transforming growth factor-beta expression during mouse prostate morphogenesis.
Timme TL; Truong LD; Merz VW; Krebs T; Kadmon D; Flanders KC; Park SH; Thompson TC
Endocrinology; 1994 Mar; 134(3):1039-45. PubMed ID: 8119140
[TBL] [Abstract][Full Text] [Related]
28. Evidence for transforming growth factor-beta expression in human leptomeningeal cells and transforming growth factor-beta-like activity in human cerebrospinal fluid.
Johnson MD; Gold LI; Moses HL
Lab Invest; 1992 Sep; 67(3):360-8. PubMed ID: 1328762
[TBL] [Abstract][Full Text] [Related]
29. Developmental and hormonal regulation of transforming growth factor-alpha and epidermal growth factor receptor gene expression in isolated prostatic epithelial and stromal cells.
Itoh N; Patel U; Skinner MK
Endocrinology; 1998 Mar; 139(3):1369-77. PubMed ID: 9492074
[TBL] [Abstract][Full Text] [Related]
30. Secretion of transforming growth factor-beta isoforms by embryonic stem cells: isoform and latency are dependent on direction of differentiation.
Slager HG; Freund E; Buiting AM; Feijen A; Mummery CL
J Cell Physiol; 1993 Aug; 156(2):247-56. PubMed ID: 8344983
[TBL] [Abstract][Full Text] [Related]
31. Alteration of gonadotropin-releasing hormone receptor expression with the progression of prostate cancer in the Dunning rat adenocarcinoma sublines.
Tieva A; Bergh A; Damber JE
Acta Oncol; 2005; 44(3):299-303. PubMed ID: 16076703
[TBL] [Abstract][Full Text] [Related]
32. Lack of the latent transforming growth factor beta binding protein in malignant, but not benign prostatic tissue.
Eklöv S; Funa K; Nordgren H; Olofsson A; Kanzaki T; Miyazono K; Nilsson S
Cancer Res; 1993 Jul; 53(13):3193-7. PubMed ID: 7686449
[TBL] [Abstract][Full Text] [Related]
33. Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF beta 3) and altered responses to the antiproliferative effects of TGF beta.
Lee BS; Nowak RA
J Clin Endocrinol Metab; 2001 Feb; 86(2):913-20. PubMed ID: 11158066
[TBL] [Abstract][Full Text] [Related]
34. Experimental diabetes-induced regression of the rat prostate is associated with an increased expression of transforming growth factor-beta.
Ikeda K; Wada Y; Foster HE; Wang Z; Weiss RM; Latifpour J
J Urol; 2000 Jul; 164(1):180-5. PubMed ID: 10840456
[TBL] [Abstract][Full Text] [Related]
35. Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium.
Ao M; Franco OE; Park D; Raman D; Williams K; Hayward SW
Cancer Res; 2007 May; 67(9):4244-53. PubMed ID: 17483336
[TBL] [Abstract][Full Text] [Related]
36. Expression and release of the latent transforming growth factor beta binding protein by hepatocytes from rat liver.
Roth S; Schurek J; Gressner AM
Hepatology; 1997 Jun; 25(6):1398-405. PubMed ID: 9185759
[TBL] [Abstract][Full Text] [Related]
37. Latent transforming growth factor binding protein 4 (LTBP-4) is downregulated in human mammary adenocarcinomas in vitro and in vivo.
Mauel S; Kruse B; Etschmann B; von der Schulenburg AG; Schaerig M; Stövesand K; Wilcken B; Sterner-Kock A
APMIS; 2007 Jun; 115(6):687-700. PubMed ID: 17550376
[TBL] [Abstract][Full Text] [Related]
38. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
Yang F; Strand DW; Rowley DR
Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743
[TBL] [Abstract][Full Text] [Related]
39. (Latent) transforming growth factor beta in liver parenchymal cells, its injury-dependent release, and paracrine effects on rat hepatic stellate cells.
Roth S; Michel K; Gressner AM
Hepatology; 1998 Apr; 27(4):1003-12. PubMed ID: 9537440
[TBL] [Abstract][Full Text] [Related]
40. Transdifferentiation of prostate cancer cells to a neuroendocrine cell phenotype in vitro and in vivo.
Burchardt T; Burchardt M; Chen MW; Cao Y; de la Taille A; Shabsigh A; Hayek O; Dorai T; Buttyan R
J Urol; 1999 Nov; 162(5):1800-5. PubMed ID: 10524938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
